Glucose
- Generic Name
- Glucose
- Brand Names
- Bss Ophthalmic Solution, Citrasate, Clinimix 2.75/5, Clinimix E 2.75/5, Dextroject, Dianeal, H.E.L.P.bicel, Hemosate Ultra, Lactate 1-2-3, Leukotrap, Naturalyte, Nauzene, Normosol-R, Nxstage Pureflow, Olimel, Periolimel, Physioneal 40, Sag-M, Sclerodex, Selectbag One
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- IY9XDZ35W2
- Background
Glucose is a simple sugar (monosaccharide) generated during phosynthesis involving water, carbon and sunlight in plants. It is produced in humans via hepatic gluconeogenesis and breakdown of polymeric glucose forms (glycogenolysis). It circulates in human circulation as blood glucose and acts as an essential energy source for many organisms through aerobic o...
- Indication
Glucose pharmaceutical formulations (oral tablets, injections) are indicated for caloric supply and carbohydrate supplementation in case of nutrient deprivation. It is also used in metabolic disorders such as hypoglycemia.
- Associated Conditions
- Arrhythmia, Caloric Deficit, Edema of the cerebrum, Hypoglycemia, Metabolic Alkalosis
- Associated Therapies
- Blood Specimen Collection, Electrolyte replacement, Nutritional supplementation, Parenteral Nutrition, Parenteral rehydration therapy, Plasmapheresis, Positive cardiac inotropic effect, Total parenteral nutrition therapy, Urine alkalinization therapy, Fluid and electrolyte maintenance therapy
HDP vs NS Intra-articular Injection Among KOA With Obese Patient
- Conditions
- Interventions
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2023-10-18
- Target Recruit Count
- 40
- Registration Number
- NCT05966948
- Locations
- 🇮🇩
Rumah Sakit Umum Daerah Haji Provinsi Jawa Timur, Indonesia, Surabaya, East Java, Indonesia
Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum Resection
- Conditions
- Interventions
- First Posted Date
- 2023-07-12
- Last Posted Date
- 2023-07-12
- Lead Sponsor
- CHU de Quebec-Universite Laval
- Target Recruit Count
- 220
- Registration Number
- NCT05941806
- Locations
- 🇨🇦
Hotel Dieu de Quebec, Québec, Que, Canada
🇨🇦Hôpital Saint-François d'Assise, Québec, Canada
Dextrose Therapy on Physical Therapy in Subdeltoid Bursitis
- Conditions
- Interventions
- First Posted Date
- 2023-06-26
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Taipei Medical University
- Target Recruit Count
- 46
- Registration Number
- NCT05918146
- Locations
- 🇨🇳
Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion
- Conditions
- Interventions
- First Posted Date
- 2022-03-03
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 60
- Registration Number
- NCT05264727
- Locations
- 🇺🇸
Mayo Clinic Rochester, Rochester, Minnesota, United States
Comparison of the Efficacy of Prolotherapy Injection Therapy & Local Anesthetic Injection Therapy.
- Conditions
- Interventions
- First Posted Date
- 2022-02-14
- Last Posted Date
- 2023-12-13
- Target Recruit Count
- 28
- Registration Number
- NCT05239091
- Locations
- 🇹🇷
Istanbul Physical Medicine Rehabilitation Hospital, Istanbul, Turkey
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)
- Conditions
- Interventions
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 340
- Registration Number
- NCT04895358
- Locations
- 🇺🇸
Parkview Research Center at Parkview Regional Medical Center ( Site 0071), Fort Wayne, Indiana, United States
🇺🇸University of Illinois at Chicago ( Site 0061), Chicago, Illinois, United States
🇫🇷Institut de Cancérologie de l'Ouest ( Site 0915), ANGERS cedex 02, Maine-et-Loire, France
Dynamic Connectivity Under Metabolic Constraints
- Conditions
- Interventions
- First Posted Date
- 2021-04-09
- Last Posted Date
- 2023-01-12
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT04840095
- Locations
- 🇺🇸
Martinos Center for Biomedical Research, Building 149, Charlestown, Massachusetts, United States
🇺🇸Bioengineering Building , Stony Brook University, Stony Brook, New York, United States
Intravesical Injection of Dextrose to Improve Lower Urinary Tract Symptoms Caused by Chronic Cystitis
- Conditions
- Interventions
- First Posted Date
- 2021-03-30
- Last Posted Date
- 2021-04-05
- Lead Sponsor
- National Defense Medical Center, Taiwan
- Target Recruit Count
- 29
- Registration Number
- NCT04821882
- Locations
- 🇨🇳
National Defense of Medical Center, Tri-Service General Hospital, Taipei city, Taiwan
Hypertonic Dextrose Versus Corticosteroid Intra-Articular Injections for the Treatment of Trapeziometacarpal Arthritis
- Conditions
- Interventions
- First Posted Date
- 2021-03-10
- Last Posted Date
- 2021-03-16
- Target Recruit Count
- 130
- Registration Number
- NCT04791202
The Use of Sedation Drugs in the Procedure of Administering Surfactant Without Intubation (LISA/MIST)
- Conditions
- Interventions
- First Posted Date
- 2020-06-01
- Last Posted Date
- 2022-01-19
- Lead Sponsor
- Medical University of Warsaw
- Target Recruit Count
- 60
- Registration Number
- NCT04409665
- Locations
- 🇵🇱
Uniwersyteckie Centrum Zdrowia Kobiety Noworodka, Warsaw, Mazowieckie, Poland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.